Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Kabraji S, Solé X, Huang Y, Bango C, Bowden M, Bardia A, et al. AKT1 quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer. Breast Cancer Res. 2017;19(1):88.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, et al. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017;17(1):28-41.

Shah K, Tran AN, Magro CM, Zang JB. Treatment of Kimura disease with mycophenolate mofetil monotherapy. JAAD Case Rep. 2017;3(5):416-419.

Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, et al. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. 2017;123(21):4130-4138.

Hainline C, Rucker JC, Zagzag D, Golfinos JG, Lui YW, Liechty B, et al. Tumoral Presentation of Homonymous Hemianopia and Prosopagnosia in Cerebral Amyloid Angiopathy-Related Inflammation. J Neuroophthalmol. 2017;37(1):48-52.

Halteh P, Magro C, Lipner SR. Angiolymphoid hyperplasia with eosinophilia of the nail unit. Dermatol Online J. 2017;23(6).

Alter RA, White TG, Fanous AA, Chakraborty S, Filippi CG, Pisapia DJ, et al. Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma. J Exp Ther Oncol. 2017;12(1):67-71.

Aukes K, Forsman C, Brady NJ, Astleford K, Blixt N, Sachdev D, et al. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions. PLoS One. 2017;12(10):e0185736.

Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, et al. Personalized and Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462-477.

Jia L, Yan F, Cao W, Chen Z, Zheng H, Li H, et al. Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. J Biol Chem. 2017;292(7):2966-2978.